
Eli Lilly and Co
LLY738.210USD
Today
-6.46%
5 Days
-10.13%
1 Month
-20.59%
6 Months
-16.78%
Year to Date
-4.37%
1 Year
-5.86%
Agency Rating
Analyst Rating
Peer Comparison
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
News
Facing a Trumpcession: What Options Remain for Stock Investors?
TradingKey - While Wednesday's CPI data came in below expectations, alleviating some market fears, intra-day trading remained volatile, indicating that investors are still seeking more data for further assessment.

BRIEF-Organovo’S FXR Program, Including FXR314, To Be Acquired By Eli Lilly And Company
Feb 25 (Reuters) - Eli Lilly and Co LLY.N:ORGANOVO’S FXR PROGRAM, INCLUDING FXR314, TO BE ACQUIRED BY ELI LILLY AND COMPANY ORGANOVO HOLDINGS INC - TO RECEIVE UPFRONT PAYMENT AND MILESTONES FOR FXR314 ORGANOVO HOLDINGS INC - LILLY ACQUIRES ALL COMMERCIAL AND IP RIGHTS TO FXR PROGRAM
.jpg)